Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,750 | 1,647 | 1,130 | 701 | 162 |
| Cost of Goods | 71 | 166 | 31 | 70 | 7 |
| Gross Profit | 1,679 | 1,481 | 1,099 | 631 | 155 |
| Operating Expenses | 65,443 | 57,001 | 46,463 | 47,438 | 49,793 |
| Operating Income | -63,693 | -55,354 | -45,333 | -46,737 | -49,631 |
| Interest Expense | 4,562 | 2,211 | 4,948 | 5,421 | 3,899 |
| Other Income | 3,444 | 4,136 | 1,884 | 2,402 | 3,005 |
| Pre-tax Income | -64,811 | -53,429 | -48,397 | -49,756 | -50,525 |
| Net Income Continuous | -64,811 | -53,429 | -48,397 | -49,756 | -50,525 |
| Net Income | $-64,811 | $-53,429 | $-48,397 | $-49,756 | $-50,525 |
| EPS Basic Total Ops | -0.18 | -0.17 | -0.20 | -0.20 | -0.21 |
| EPS Basic Continuous Ops | -0.18 | -0.17 | -0.20 | -0.21 | -0.21 |
| EPS Diluted Total Ops | -0.18 | -0.17 | -0.20 | -0.20 | -0.21 |
| EPS Diluted Continuous Ops | -0.18 | -0.17 | -0.20 | -0.21 | -0.21 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.17 | -0.20 | N/A | N/A |
| EBITDA(a) | $-63,165 | $-54,690 | $-44,672 | $-45,972 | $-48,862 |